GLA and depressive symptom measurement: There was no change in Center for Epidemiologic Studies Depression Scale (CES-D) score upon switching from agalsidase beta 1.0 mg/kg EOW to agalsidase alfa 0.2 mg/kg EOW in one relatively large, mixed-ERT OS publication (in 105 patients followed for 8–16 months) [181].